 SHANGHAI and GAITHERSBURG, MD, March 18, 2022 PRNewswire -- I-Mab the Company Nasdaq: IMAB, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the Company will report financial results for the full year ended December 31, 2021 before the market opens on Tuesday, March 29, 2022, and host a conference call to discuss the results and provide a corporate update at 8:00 a.m. EST. I-Mab Conference Call Information Investors and analysts are invited to join the conference call at 8:00 a.m. 